Newer developments in the treatment of Gram-positive infections

By Koomanachai Pornpan   Crandon Jared L   Nicolau David P  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 17, 2009-12 ,pp. : 2829-2843

Informa Healthcare

Access to resources Recommend Favorite

Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections

By Eisenstein Barry I  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 9, 2004-09 ,pp. : 1159-1169

Informa Healthcare

Access to resources Recommend Favorite

Novel agents for the treatment of resistant Gram-positive infections

By Woodford Neil  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 117-137

Informa Healthcare

Access to resources Recommend Favorite

Benefit-Risk Assessment of Linezolid for Serious Gram-Positive Bacterial Infections

By Falagas Matthew E.   Vardakas Konstantinos Z.  

Drug Safety, Vol. 31, Iss. 9, 2008-01 ,pp. : 753-768

Adis International

Access to resources Recommend Favorite

Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumonia

By Rubinstein Ethan   Corey G Ralph   Stryjewski Martin E   Kanafani Zeina A  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 17, 2011-12 ,pp. : 2737-2750

Informa Healthcare

Access to resources Recommend Favorite